1. 1496PEORTC experience with advanced/metastatic epithelioid sarcoma patients treated in prospective trials: Clinical profile and response to systemic therapy. (18th September 2017) Authors: Touati, N.; Schoffski, P.; Litière, S.; Judson, I.; Sleijfer, S.; van der Graaf, W.T.A.; Italiano, A.; Isambert, N.; Gil, T.; Blay, J-Y.; Stark, D.; Brodowicz, T.; Marreaud, S.; Gronchi, A. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3439 Prognostic factors in soft tissue sarcoma patients with lung metastases only receiving first-line chemotherapy. An exploratory, retrospective analysis on fifteen trials of the European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). (September 2015) Authors: Lindner, L.; Litiere, S.; Sleijfer, S.; Judson, I.; Italiano, A.; Kasper, B.; Gelderblom, H.; Marreaud, S.; Wardelmann, E.; Gronchi, A.; Graaf, W. Van der Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials. Issue 17 (November 2015) Authors: Duffaud, F.; Sleijfer, S.; Litière, S.; Ray-Coquard, I.; Le Cesne, A.; Papai, Z.; Judson, I.; Schöffski, P.; Chawla, S.P.; Dewji, R.; Marreaud, S.; Verweij, J.; van der Graaf, W.T. Journal: European journal of cancer Issue: Volume 51:Issue 17(2015:Nov.) Page Start: 2615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0278 Accelerated CH-RT with/without nimorazole for p16- HNSCC: the randomized DAHANCA 29-EORTC 1219 trial. (August 2021) Authors: Grégoire, V.; Tao, Y.; Kaanders, J.; Machiels, J.; Vulquin, N.; Nuyts, S.; Fortpied, C.; Lmalem, H.; Marreaud, S.; Overgaard, J. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis. (2nd January 2017) Authors: Kollár, A.; Jones, R. L.; Stacchiotti, S.; Gelderblom, H.; Guida, M.; Grignani, G.; Steeghs, N.; Safwat, A.; Katz, D.; Duffaud, F.; Sleijfer, S.; van der Graaf, W. T.; Touati, N.; Litière, S.; Marreaud, S.; Gronchi, A.; Kasper, B. Journal: Acta oncologica Issue: Volume 56:Number 1(2017) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗